Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Anja Löw"'
Autor:
Michael Berger, Florian Seemüller, Alessandra Voggt, Michael Obermeier, Franca Kirchberg, Anja Löw, Michael Riedel, Clemens von Schacky, Emanuel Severus
Publikováno v:
International Journal of Bipolar Disorders, Vol 10, Iss 1, Pp 1-11 (2022)
Abstract Background Research suggests that a low omega-3 index may contribute to the low heart rate variability and the increased risk of cardiovascular morbidity and mortality in bipolar disorders. However, so far, no intervention trial with EPA and
Externí odkaz:
https://doaj.org/article/682a0327963e4ba2840dfc74c9532218
Publikováno v:
Vasa. 51:323-325
Autor:
Claire Davidson, Shahela Islam, Enrico Venturini, Anja Lowit, Christopher Gillberg, Helen Minnis
Publikováno v:
JCPP Advances, Vol 4, Iss 3, Pp n/a-n/a (2024)
Abstract Background Children with Disinhibited Social Engagement Disorder (DSED) have specific difficulties with indiscriminate sociability, yet little is known about their broader social competencies as DSED tends not to be identified within samples
Externí odkaz:
https://doaj.org/article/ab5d225ad8bf48519457fad1d157e34f
Autor:
Axel Bauer, Michael Schreinlechner, Nikolay Sappler, Theresa Dolejsi, Herbert Tilg, Benedikt A Aulinger, Günter Weiss, Rosa Bellmann-Weiler, Christian Adolf, Dominik Wolf, Markus Pirklbauer, Ivo Graziadei, Hannes Gänzer, Christian von Bary, Andreas E May, Ewald Wöll, Wolfgang von Scheidt, Tienush Rassaf, Daniel Duerschmied, Christoph Brenner, Stefan Kääb, Bernhard Metzler, Michael Joannidis, Hans-Ulrich Kain, Norbert Kaiser, Robert Schwinger, Bernhard Witzenbichler, Hannes Alber, Florian Straube, Niels Hartmann, Stephan Achenbach, Michael von Bergwelt-Baildon, Lukas von Stülpnagel, Sebastian Schoenherr, Lukas Forer, Sabine Embacher-Aichhorn, Ulrich Mansmann, Konstantinos D Rizas, Steffen Massberg, Marcin Bantkowiak, Gabriele Baur, Monika Baylacher, Marcel Beaucamp, Manuel Berger, Lisa Besch, Stefan Brunner, Stephan Budweiser, Heiko Bugger, Raffaele Coletti, Uwe Dorwarth, Jozsef Egresits, Elodie Eiffener, Christian Faul, Armin Finkenstedt, Konstantinos Gatos, Nadine Gauchel, Frank Gindele, Wilhelm Grander, Markus Gunschl, Frank Hartig, Moritz Hecht, Tobias Heer, Lukas Heger, Marcus Hentrich, Lena Horvath, Dritan Keta, Stefan Kiechl, Rudolf Kirchmaier, Andreas Klein, Mathias Klemm, Ewald Kolesnik, Andreas König, Hans Christian Kossmann, Jana Kropacek, Lukas Lanser, Achim Lother, Anja Löw, Amir-Abbas Mahabadi, Stefan Malleier, Gert Mayer, Christoph Müller, Dirk Müller-Wieland, Bernhard Nagel, Hannes Neuwirt, Christoph Olivier, Thomas Raunegger, Martin Reindl, Sebastian Reinstadler, Lisa Riesinger, Michael Schäffner, Johannes Schier, Julia Schock, Peter Schönherr, Martina Schulz, Thomas Schütz, Johannes Schwarz, Johannes Siebermair, Marcus Siry, Anna Spaur, Wolfgang Sturm, Kristin Tessadri, Fabian Theurl, Markus Theurl, Liz Thommes, Christina Tiller, Michael Toifl, Matthias Totzeck, Hedda von zur Mühlen, Nadine Vonderlin, Reza Wakili, Clemens Wendtner, Felix Wenner, Daniela Wimmert-Roidl, August Zabernigg
Publikováno v:
The Lancet. Respiratory Medicine
Summary Background SARS-CoV-2 entry in human cells depends on angiotensin-converting enzyme 2, which can be upregulated by inhibitors of the renin–angiotensin system (RAS). We aimed to test our hypothesis that discontinuation of chronic treatment w
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2a74084d73fac3013dc238aefb5a26a6
https://www.ncbi.nlm.nih.gov/pubmed/34126053
https://www.ncbi.nlm.nih.gov/pubmed/34126053
Autor:
Dirk Sibbing, Dániel Aradi, Claudius Jacobshagen, Lisa Gross, Dietmar Trenk, Tobias Geisler, Martin Orban, Martin Hadamitzky, Béla Merkely, Róbert Gábor Kiss, András Komócsi, Csaba A Dézsi, Lesca Holdt, Stephan B Felix, Radoslaw Parma, Mariusz Klopotowski, Robert H G Schwinger, Johannes Rieber, Kurt Huber, Franz-Josef Neumann, Lukasz Koltowski, Julinda Mehilli, Zenon Huczek, Steffen Massberg, Zofia Parma, Maciej Lesiak, Anna Komosa, Michal Kowara, Bartosz Rymuza, Lukasz Malek, Daniel Aradi, Gábor Veress, András Döme Dézsi, Árpád Lux, Judit Papp, Andrea Kovács, Csaba András Dézsi, Sayour Amer, Zoltán Ruzsa, Szilárd Róna, Renáta Ili, Imre Ungi, Ferenc Nagy, Robert Zweiker, Gábor Tóth-Gayor, Paul Haller, Wolfgang von Scheidt, Andreas Blüthgen, Stefan Leggewie, Hans Ulrich Kreider-Stempfle, Thomas Remp, Kaffer Kara, Andreas Mügge, Alexander Wutzler, Stephan Fichtlscherer, Andreas M. Zeiher, Florian Seeger, Martin Hinterseer, Andreas König, Susanne Lederle, Frauke Czepluch, Lars Maier, Wolfgang Schillinger, Samuel Sossalla, Astrid Hummel, Stephan Felix, Mahir Karakas, Karsten Sydow, Tanja Rudolph, Marcel Halbach, Tommaso Gori, Thomas Münzel, Andreas May, Carsten-Manuel Gerstenberg, David Pilecky, Markus Deichstetter, Stefan Kääb, Anja Löw, Matthias Orban, Stefan Sattler, Sabine Deuschl, Daniel Teupser, Harald Mudra, Thomas Räder, Torsten Schütz, Felix Vahldiek, Dimitar Divchev, Hüseyin Ince, Christoph A Nienaber, Henning Radunski, Peter Boekstegers, Jan Horstkotte, Ralf Mueller, Karin Müller, Robert Schwinger, Oliver Rasp
Publikováno v:
The Lancet. 390:1747-1757
Summary Background Current guidelines recommend potent platelet inhibition with prasugrel or ticagrelor for 12 months after an acute coronary syndrome managed with percutaneous coronary intervention (PCI). However, the greatest anti-ischaemic benefit
Autor:
Lisa Gross, Béla Merkely, Róbert Gábor Kiss, Zenon Huczek, Johannes Rieber, Lukasz A. Malek, Franz-Josef Neumann, Julinda Mehilli, Andreas Thalmeier, Martin Hadamitzky, Tobias Geisler, Tommaso Gori, Anja Löw, Hüseyin Ince, Kurt Huber, Daniel Aradi, Radosław Parma, Steffen Massberg, Robert H. G. Schwinger, Daniel Teupser, Jörg Hausleiter, András Komócsi, Lukasz Koltowski, Monika Baylacher, Claudius Jacobshagen, Csaba András Dézsi, Dirk Sibbing, Martin Orban, Dietmar Trenk, Lesca M. Holdt, Jan Horstkotte, Stephan B. Felix, Harald Mudra
Publikováno v:
Thrombosis and Haemostasis. 117:188-195
SummaryOutcomes of acute coronary syndrome (ACS) patients undergoing percutaneous coronary intervention (PCI) have been significantly improved with the use of potent P2Y12 receptor inhibitors like prasugrel. While most of the ischaemic risk reduction
Autor:
Lisa Gross, Martin Orban, Konstantinos D. Rizas, Róbert Gábor Kiss, Anja Löw, Danny Kupka, Ralph Hein-Rothweiler, Dirk Sibbing, Steffen Massberg, Monika Baylacher, Kurt Huber, Martin Hadamitzky, Bo Eric Beuthner, Tobias Geisler, Claudius Jacobshagen, Béla Merkely, Zenon Huczek, Daniel Aradi, Dietmar Trenk
Publikováno v:
Thrombosis and haemostasis. 119(9)
Objectives This prespecified analysis of the TROPICAL-ACS trial aimed to assess the impact of gender on clinical outcomes and platelet reactivity (PR) following guided de-escalation of dual antiplatelet treatment (DAPT) in acute coronary syndrome (AC
Publikováno v:
AMRC Open Research, Vol 3 (2023)
Background: Progressive ataxias are complex disorders that result in a wide variety of symptoms. Whilst we currently have a relatively good understanding of the spectrum of symptoms associated with the various types of ataxia, and their progression o
Externí odkaz:
https://doaj.org/article/7e7e66ba3ac74303aca65832aecc9015
Autor:
Michael Riedel, Michael Obermeier, A. Voggt, R. Zimmermann, Anja Löw, H.-J. Moeller, C. von Schacky, Michael Berger, F. Kirchberg, Emanuel Severus, F. Seemueller
Publikováno v:
European psychiatry : the journal of the Association of European Psychiatrists. 30(2)
Background:Affective disorders are associated with an increased risk of cardiovascular disease, which, at least partly, appears to be independent of psychopharmacological treatments used to manage these disorders. Reduced heart rate variability (SDNN
Publikováno v:
The British journal of nutrition. 104(5)
There is strong evidence that the intake of EPA and DHA reduces the risk of adverse cardiac events. Fish and fish oil capsules are not necessarily an ideal source of EPA and DHA for every individual. The aim of the present study was to evaluate the e